Find therapies in clinical trials near you – page 27

Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections

Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

Study on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Long-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency

Long-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency

Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage